Chemocentryx, inc. (CCXI)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Operating activities
Net loss

-55,489

-37,966

17,859

-39,963

-47,305

-46,929

-38,673

-39,891

-4,617

-3,096

Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation

11,638

10,833

8,748

8,535

8,985

8,214

6,242

4,953

2,642

2,346

Depreciation of property and equipment

550

512

418

348

477

543

576

592

754

660

Amortization of right-of-use assets

1,092

0

0

-

-

-

-

-

-

-

Non-cash interest income, net

1,499

1,071

-143

-179

-1,007

-2,157

-2,065

-2,571

-2,021

939

Changes in assets and liabilities:
Accounts receivable, other

176

0

0

-

-

-

-

-

-

-

Accounts receivable

-2,058

-49,032

20,885

30,205

-

-393

-763

649

-11,945

-22,989

Prepaids and other current assets

-719

668

727

-35

-236

376

-34

-692

764

-395

Other assets

-61

31

80

119

-

21

-

-1,935

1,935

-17

Accounts payable

188

-434

729

-4

-73

-161

159

214

-405

-103

Other liabilities

4,459

4,158

80

3,773

-2,654

1,865

-723

1,758

-2,593

779

Deferred revenue from related party

-33,724

-7,929

-1,407

96,566

-

-

-3,761

-4,402

-3,628

-6,289

Net cash used in operating activities

-70,123

16,436

4,878

39,145

-39,327

-34,315

-33,318

-32,227

3,420

18,637

Investing activities
Purchases of property and equipment, net

790

838

723

304

218

352

554

472

166

1,193

Purchases of investments

211,973

192,480

133,845

136,234

24,372

100,837

136,600

177,566

113,251

90,258

Sales of investments

4,967

0

0

-

4,051

-

5,142

5,582

17,260

-

Maturities of investments

195,270

140,250

150,170

87,774

54,423

139,528

100,344

115,552

109,352

62,849

Net cash provided by (used in) investing activities

-12,526

-53,068

15,602

-48,764

33,884

38,339

-31,668

-56,904

13,195

-28,602

Financing activities
Proceeds from issuance of common stock

73,276

0

0

7,000

-

-

64,365

57,017

-

-

Proceeds from exercise of stock options

22,857

10,467

3,269

1,820

2,191

2,123

2,678

966

260

117

Employees' tax withheld and paid for restricted stock units

1,313

678

429

-

-

-

-

-

-

-

Borrowings under credit facility agreement, net of issuance costs

0

14,911

4,676

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

312

-

1,058

-

Proceeds from the issuance of convertible note

-

-

-

-

-

-

-

-

10,000

-

Proceeds from equipment financing obligations

-

-

-

-

-

-

-

-

700

1,500

Payments on equipment financing obligations

-

-

-

-

-

330

571

547

534

672

Net cash provided by financing activities

94,820

24,700

7,516

8,820

2,191

1,793

66,784

57,436

11,484

945

Net increase in cash, cash equivalents and restricted cash

12,171

-11,932

27,996

-799

-3,252

5,817

1,798

-31,695

28,099

-9,020

Supplemental disclosures of cash flow information
Cash paid for interest

1,735

748

0

-

-

137

26

50

87

130

Right-of-use assets obtained in exchange for lease obligations

2,796

0

0

-

-

-

-

-

-

-

Purchases of property and equipment, net recorded in accounts payable

378

0

0

-

-

-

-

-

-

-

Cash refund for income taxes

-

-

-

-

-

-

-

-

16

247

Issuance of common stock for settlement of convertible debt, including accrued interest

-

-

-

-

-

-

-

10,215

-

-